1 / 19

Interactive Introduction cost effectiveness

Interactive Introduction cost effectiveness. Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD) Jan.Busschbach@deviersprong.nl +31 164 632200 Department of Medical Psychology & Psychotherapy, Erasmus University Medical Center. New cancer therapy.

alan-acosta
Download Presentation

Interactive Introduction cost effectiveness

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD) Jan.Busschbach@deviersprong.nl +31 164 632200 Department of Medical Psychology & Psychotherapy, Erasmus University Medical Center

  2. New cancer therapy Symptoms Drug X Drug Y Survival days 300 400 Days sick of chemotherapy 10 150 Days sick of disease 100 30 TWiST 190 220

  3. Time Without Symptoms of disease and subjective Toxic effects of treatment • TWiST • Developed by Richard Gelber (statistician) • In search for a typical “cancer” problem • Often prolonged life but also a reductions in quality of life • At the beginning (side effects) • At the end • Only count the days without symptoms of disease and subjective toxic effects of the treatment

  4. Fit new therapy in fixed budget • 50 patients each year (per hospital) • Drug x: 50 x euro 1.750 = euro 87.500 • Drug y: 50 x euro 2.000 = euro 100.000 • Drug budget for x or y = euro 50.000 • Number of patient • Drug x: euro 50.000 / 1.750 = 28.5 patients • Drug y: euro 50.000 / 2.000 = 25.0 patients • Survival in days • Drug x: 28.5 patients x 300 days = 8.550 days • Drug y: 25.0 patients x 400 days = 10.000 days • Survival in TWiST • Drug x: 28.5 patients x 190 TWiST = 5.415 days • Drug y: 25.0 patients x 220 TWiST = 5.500 days

  5. TWiST: ignores differences in quality of life 0.0 Quality of life 1.0 • TWiST • Healthy = 1 • Sick (dead) = 0 • There is more to life than sick/health • Make intermediate values • Q-TWiST • Quality of life adjusted adjusted TWiST • How to scale quality of life?

  6. Value a health state • Wheelchair • Some problems in walking about • Some problems washing or dressing • Some problems with performing usual activities • Some pain or discomfort • No psychosocial problems

  7. Time Trade-Off • TTO • Wheelchair • With a life expectancy: 50 years • How many years would you trade-off for a cure? • Max. trade-off is 10 years • QALY(wheel) = QALY(healthy) • Y * V(wheel) = Y * V(healthy) • 50 V(wheel) = 40 * 1 • V(wheel) = .80

  8. EuroQol EQ-5D:of the shelf QALY value • MOBILITY • I have no problems in walking about • I have some problems in walking about • I am confined to bed • SELF-CARE • I have no problems with self-care • I have some problems washing or dressing myself • I am unable to wash or dress myself • USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities) • I have no problems with performing my usual activities • I have some problems with performing my usual activities • I am unable to perform my usual activities • PAIN/DISCOMFORT • I have no pain or discomfort • I have moderate pain or discomfort • I have extreme pain or discomfort • ANXIETY/DEPRESSION • I am not anxious or depressed • I am moderately anxious or depressed • I am extremely anxious or depressed

  9. In health economics: Q-TWiST = QALY • Count life years • Value (V) quality of life (Q) • V(Q) = [0..1] • 1 = Healthy • 0 = Dead • One dimension • Adjusted life years (Y) for value quality of life • QALY = Y * V(Q) • Y: numbers of life years • Q: health state • V(Q): the value of health state Q • Also called “utility analysis”

  10. Which health care program is the most cost-effective? • A new wheelchair for elderly (iBOT) • Special post natal care

  11. Which health care program is the most cost-effective? • A new wheelchair for elderly • Increases quality of life = 0.1 • 10 years benefit • Extra costs: $ 3,000 per life year • QALY = Y x V(Q) = 10 x 0.1 = 1 QALY • Costs are 10 x $3,000 = $30,000 • Cost/QALY = 30,000/QALY • Special post natal care • Quality of life = 0.8 • 35 year • Costs are $250,000 • QALY = 35 x 0.8 = 28 QALY • Cost/QALY = 8,929/QALY

  12. Effect psychotherapy

  13. Example STIP • Short-Term Inpatient Psychotherapy • Cost price • Per patient day: €210.34 • 3 mouths = 91.3 day • 91.3 x 210 = €19,194.53 • Includes overhead • Buildings, administration, etc • Excluding • Savings elsewhere in health care system • Effect • Assume quality of life increase of 0.25 • Over 10 year • Cost / QALY • 19,194.54 / (10 x 0.25) = €7,677.41 Although gold standard…Cost per QALY of psychotherapy have never been published

  14. QALY league table

  15. Egalitarian Concerns:Burden of disease 1.0 Utility of Health 0.0 A B C

  16. Implications shifting threshold • QALY are weighted • Weighted QALYs are maximized • Health is no longer the only thing maximized • Health status population will drop • Differences in health will drop • Egalitarian consideration are incorporated • Burden of disease becomes a criteria • Equity

  17. CE-ratio by equity

  18. Burden of disease based on STEP-data (N = 641)

  19. Conclusion • Introduce state-of-the-art cost effectiveness studies • Measure costs and outcome • Suitable for cost effectiveness studies • According to guidelines • Establish burden of disease • State-of-the-art quality of life research • Use an active approach on budget constrains • Anticipate on policy arguments • Look for beyond own discipline

More Related